COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, Prabhat Jha
doi: https://doi.org/10.1101/2021.03.04.21252540
University of Toronto
Prabhat Jha
University of Toronto
Article usage
Posted March 05, 2021.
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
Action to beat coronavirus/Action pour battre le coronavirus (Ab-C) Study Investigators, Prabhat Jha
medRxiv 2021.03.04.21252540; doi: https://doi.org/10.1101/2021.03.04.21252540
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (660)
- Anesthesia (177)
- Cardiovascular Medicine (2579)
- Dermatology (218)
- Emergency Medicine (390)
- Epidemiology (12106)
- Forensic Medicine (10)
- Gastroenterology (750)
- Genetic and Genomic Medicine (4010)
- Geriatric Medicine (377)
- Health Economics (670)
- Health Informatics (2588)
- Health Policy (993)
- Hematology (357)
- HIV/AIDS (827)
- Medical Education (397)
- Medical Ethics (107)
- Nephrology (424)
- Neurology (3777)
- Nursing (207)
- Nutrition (560)
- Oncology (1968)
- Ophthalmology (574)
- Orthopedics (233)
- Otolaryngology (301)
- Pain Medicine (248)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1092)
- Primary Care Research (442)
- Public and Global Health (6449)
- Radiology and Imaging (1371)
- Respiratory Medicine (864)
- Rheumatology (394)
- Sports Medicine (336)
- Surgery (434)
- Toxicology (51)
- Transplantation (185)
- Urology (165)